ATE135015T1 - Vasodilatierende und immunsupprimierende peptide - Google Patents

Vasodilatierende und immunsupprimierende peptide

Info

Publication number
ATE135015T1
ATE135015T1 AT90911134T AT90911134T ATE135015T1 AT E135015 T1 ATE135015 T1 AT E135015T1 AT 90911134 T AT90911134 T AT 90911134T AT 90911134 T AT90911134 T AT 90911134T AT E135015 T1 ATE135015 T1 AT E135015T1
Authority
AT
Austria
Prior art keywords
proteins
immunosumptimizing
vasodilating
peptides
mammal
Prior art date
Application number
AT90911134T
Other languages
English (en)
Inventor
Ethan A Lerner
Heinz G Remold
Jose M C Ribeiro
Richard G Titus
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Application granted granted Critical
Publication of ATE135015T1 publication Critical patent/ATE135015T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43577Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT90911134T 1989-06-29 1990-06-29 Vasodilatierende und immunsupprimierende peptide ATE135015T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37408089A 1989-06-29 1989-06-29

Publications (1)

Publication Number Publication Date
ATE135015T1 true ATE135015T1 (de) 1996-03-15

Family

ID=23475190

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90911134T ATE135015T1 (de) 1989-06-29 1990-06-29 Vasodilatierende und immunsupprimierende peptide

Country Status (7)

Country Link
EP (1) EP0479899B1 (de)
JP (1) JPH06502385A (de)
AT (1) ATE135015T1 (de)
AU (1) AU5966490A (de)
CA (1) CA2063260A1 (de)
DE (1) DE69025763T2 (de)
WO (1) WO1991000293A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397772A (en) * 1989-06-29 1995-03-14 The President And Fellows Of Harvard College Vasodilatory peptides from the salivary gland of the sand fly Lutzomyia longipalpis
US5294543A (en) * 1992-04-08 1994-03-15 The General Hospital Corporation Inhibitor of platelet aggregation
CA2155866A1 (en) * 1993-02-12 1994-08-18 Jose M. C. Ribeiro Method of enhancing hair growth and hair revitalizing compositions comprising lutzomyia protein
US5480864A (en) * 1993-08-06 1996-01-02 Shiseido Co., Ltd. Modified maxadilan protein, its preparation and use, and DNA encoding the protein
KR100361933B1 (ko) 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
KR950007873A (ko) * 1993-09-20 1995-04-15 후꾸하라 요시하루 생리 활성 물질 지속 방출형의 의약 제제
US6462016B1 (en) 1995-10-06 2002-10-08 Shiseido Company, Ltd. Method for screening agonist or antagonist of the maxadilan receptor participating in vasodilating action, and compound found by the method

Also Published As

Publication number Publication date
EP0479899B1 (de) 1996-03-06
WO1991000293A1 (en) 1991-01-10
CA2063260A1 (en) 1990-12-30
AU5966490A (en) 1991-01-17
JPH06502385A (ja) 1994-03-17
DE69025763T2 (de) 1996-09-05
EP0479899A1 (de) 1992-04-15
DE69025763D1 (de) 1996-04-11

Similar Documents

Publication Publication Date Title
DK672788A (da) Rekombinant-dna-vektorer til direkte udtrykkelse af aktiveret humant protein c
DE3587958D1 (de) Rekombinantes alveolares oberflächenaktives protein.
RU95115239A (ru) Аналог эритропоэтина
DZ467A1 (fr) Interferon immunitaire urbain.
FI102379B1 (fi) Uretaanisuojattuja aminohappo-N-karboksianhydridejä
ATE114163T1 (de) Exprimierung in säugetieren der bmp-2 familie.
NO972264D0 (no) Fremgangsmåter for behandling av multippel sklerose ved bruk av peptidanaloger av human myelin basis protein
KR840005739A (ko) 인체릴랙신(relaxin)을 암호하는 유전자의 분리방법 및 릴랙신 활성을 갖는 폴리펩티드의 제조방법
PT85977A (en) Process for the preparation of human apolipoprotein ai and their variant forms by recombinant dna methods
DE3685626D1 (de) Sequenzierung von peptiden.
DK447684A (da) Homogent immuninterferon
DK175843B1 (da) Polypeptider af overfladeaktive alvelolarproteiner (ASP), farmaceutisk sammensætning indeholdende polypeptidet, DNA-ekspressionssystem der koder for polypeptidet, samt fremgangsmåde til fremstilling af polypeptider med ASP-aktivitet
DK0975761T3 (da) Humant, rekombinant beta-interferon med forbedret opløselighed
NO169725C (no) Fremgangsmaate for fremstilling av et uglykosylert rekombinant humant immun-interferonprotein
DE69331501D1 (de) Unterdrückung der Proliferation von T-Zellen mittels Peptidfragmenten des basischen Proteins aus Myelin
ATE135015T1 (de) Vasodilatierende und immunsupprimierende peptide
FI891848A7 (fi) Eristettyjen proteiinipitoisten aineiden valmistus käyttäen lintujen rekombinanttirokkovirusvektoreja
IE870507L (en) Bovine virus diarrhea and hog cholera vaccines
ES2080060T3 (es) Proteinas que tienen actividad de union a interferon-gamma.
ES2009588A6 (es) Un metodo para la preparacion de un polipeptido.
DK2086A (da) Protraheret virkende sterilt vandigt praeparat af et peptid eller protein, dets fremstilling og anvendelse
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf
DE69330348D1 (de) Verwendung von Peptiden welche eine Immunantwort bewirken zur Herstellung von Medikamenten zur Induzierung der Immunsuppression.
FI906112A7 (fi) Menetelmiä ja koostumuksia nisäkkäiden infektioiden käsittelemiseksi k äyttämällä lääkkeitä, jotka käsittävät pistiäisten myrkkyä, sen protei ini- tai polypeptidiainesosia tai näiden porteiini- tai polypeptidiain eosien analogeja
IL86699A0 (en) Cell system for expression of recombinant protein without production of virus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties